ZHYBF (Zhong Yuan Bio-Technology Holdings) Total Long-Term Assets: $1.14 Mil (As of Mar. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ZHYBF Zhong Yuan Bio-Technology Holdings Ltd ZHYBF
12 GF Score
Price $2.02
View Full Analysis

What is Zhong Yuan Bio-Technology Holdings Total Long-Term Assets?

Zhong Yuan Bio-Technology Holdings ZHYBF -100.00% 12 Total Long-Term Assets is $1.14 Mil as of Mar. 2024. GuruFocus rates ZHYBF with a GF Score™ of 12/100.

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Zhong Yuan Bio-Technology Holdings's Total Long-Term Assets for the quarter that ended in Mar. 2024 was $1.14 Mil.

Zhong Yuan Bio-Technology Holdings Total Long-Term Assets Related Terms

Zhong Yuan Bio-Technology Holdings Total Long-Term Assets Historical Data

* Premium members only.

The historical data trend for Zhong Yuan Bio-Technology Holdings's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhong Yuan Bio-Technology Holdings Total Long-Term Assets Chart

Zhong Yuan Bio-Technology Holdings Annual Data
Trend Dec16 Dec17 Dec18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Long-Term Assets
Get a 7-Day Free Trial Premium Member Only 0.75 1.02 0.77 1.09 1.14

Zhong Yuan Bio-Technology Holdings Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.77 1.14 1.09 1.20 1.14
ZHYBF
12GF Score
Zhong Yuan Bio-Technology Holdings Ltd ZHYBF
Total Long-Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhong Yuan Bio-Technology Holdings Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Frequently Asked Questions Learn more about Total Long-Term Assets →
What does a Total Long-Term Assets of $1.14 Mil mean?
Zhong Yuan Bio-Technology Holdings (ZHYBF) has a Total Long-Term Assets of $1.14 Mil as of Mar. 2024. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Zhong Yuan Bio-Technology Holdings and its competitors.
Is Zhong Yuan Bio-Technology Holdings' Total Long-Term Assets too high?
Zhong Yuan Bio-Technology Holdings' current Total Long-Term Assets is $1.14 Mil. Overall, Zhong Yuan Bio-Technology Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Zhong Yuan Bio-Technology Holdings' Total Long-Term Assets compare to CLNN and JVA?
Zhong Yuan Bio-Technology Holdings' Total Long-Term Assets of $1.14 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Assets for a Consumer Packaged Goods company?
A good Total Long-Term Assets depends on the Consumer Packaged Goods industry context. However, Total Long-Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Assets mean?
A high Total Long-Term Assets can signal that a stock is expensive relative to its fundamentals. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Zhong Yuan Bio-Technology Holdings and its competitors. Zhong Yuan Bio-Technology Holdings's current Total Long-Term Assets is $1.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhong Yuan Bio-Technology Holdings stock overvalued right now?
Zhong Yuan Bio-Technology Holdings (ZHYBF) has a current Total Long-Term Assets of $1.14 Mil. The current Total Long-Term Assets is $1.14 Mil. Zhong Yuan Bio-Technology Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Assets calculated?
Total Long-Term Assets is calculated from a company's financial statements. For Zhong Yuan Bio-Technology Holdings (ZHYBF), the current Total Long-Term Assets is $1.14 Mil as of Mar. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zhong Yuan Bio-Technology Holdings Business Description

Address 28 Queen’s Road East, Suite 901, Tesbury Centre, Wanchai, Hong Kong, HKG
Zhong Yuan Bio-Technology Holdings Ltd is engaged in the business of developing and marketing nervonic acid-based health supplements and sales of acer truncatum seedlings. The company has two reportable segments such as sales of health care supplements and technical supporting services. The company generates its revenue primarily from the sales of health care supplements.
12GF Score

Get the complete analysis for ZHYBF

Total Long-Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.02
Price